Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
568.65 |
617.20 |
755.43 |
564.79 |
475.62 |
Operating profit |
267.24 |
261.38 |
343.60 |
236.39 |
210.60 |
Interest |
1.65 |
1.72 |
2.93 |
3.30 |
6.47 |
Gross profit |
289.85 |
280.95 |
484.34 |
277.21 |
210.23 |
EPS (Rs) |
7.82 |
7.58 |
14.20 |
7.72 |
11.51 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
24.26 |
21.29 |
143.67 |
44.12 |
6.10 |
Stock adjustment |
30.47 |
-15.31 |
-18.98 |
-41.37 |
1.19 |
Raw material |
124.57 |
196.63 |
248.76 |
210.70 |
143.18 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
52.78 |
50.68 |
56.13 |
44.35 |
38.37 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
4.31 |
4.33 |
- |
6.89 |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
93.58 |
119.51 |
121.59 |
114.72 |
75.38 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
21.63 |
21.30 |
20.93 |
18.17 |
14.56 |
Taxation |
69.20 |
66.67 |
101.95 |
62.40 |
49.10 |
Net profit / loss |
199.02 |
192.97 |
361.46 |
196.64 |
146.56 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
25.46 |
25.46 |
25.46 |
25.46 |
12.73 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
47.00 |
42.35 |
45.48 |
41.85 |
44.28 |
GPM (%) |
48.89 |
44.00 |
53.87 |
45.53 |
43.64 |
NPM (%) |
33.57 |
30.22 |
40.20 |
32.29 |
30.42 |